APOGEE THERAPEUTICS, INC.
Last · NASDAQ$135.070.00 (0.00%)stale · yahoo · 1025h ago
Vol 143.8K ≈ 19.43M
MA10MA20MA50
Market cap$10.22B62.2M sh
P/E · TTM-31.1fwd -26.0 · eps -4.34 · loss
Beta0.33vs S&P 500
Div yield—annual · TTM
52w range
$35.39$135.09
Volume—session
Issuer
Legal nameAPOGEE THERAPEUTICS, INC.
HQUnited States (US)
ListingUS APGE
ISINUS03770N1019
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001974640
CIK0001974640
Websitewww.apogeetherapeutics.com
Employees261
AddressApogee Therapeutics, Inc. 221 Crescent Street 02453, Waltham
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-02
From latest 10-K · 2026-03-02
- Operating Cf Burn
- Cash Runway Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.6 years
Upcoming earnings
MON.9NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$1.25
Est. revenue
0
Press & signals
- GlobeNewswire
Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates